

Aims: This study was aimed to compare insulin sensitivity and secretion response, lipoprotein and plasminogen activator inhibitor 1 (PAI-1) levels between the subjects with and without coronary artery endothelial dysfunction (ED). Methods: ED was detected by intracoronary injection of acetylcholine (ACh) in 47 nondiabetes subjects without stenotic coronary arteries, selected from 316 consecutive patients with coronary angiography performed for suspected coronary artery disease. The subjects were divided into two groups: presence of ACh-induced coronary spasm (group ED+, N = 30) and absence of ACh-induced coronary spasm (group ED− N = 17). Insulin sensitivity (Si) was evaluated by frequently sampled intravenous glucose tolerance test (FSIGTT) with minimal model analysis and by HOMA-IR, insulin secretion by acute insulin response (AIR) (calculated from the first 8 min of FSIGTT) and by disposition index (DI) (Si × AIR). Lipids and PAI-1 levels were determined enzymatically, and LDL particle size by gradient gel electrophoresis. Results: Si was significantly lower (4.22 ± 0.62 vs 6.98 ± 1.47 min−1/mU/l × 104; p < 0.05) while HOMA-IR was significantly higher in ED + group vs ED− group (2.8 ± 0.3 vs 1.7 ± 0.2; p < 0.05). Simultaneously, AIR and DI was significantly lower in ED + vs ED− groups (p < 0.05 and p < 0.01, respectively). Investigated groups did not differ in fasting lipid levels but ED+ group had significantly smaller LDL particles (p < 0.01) and higher PAI-1 levels (p < 0.05). Regression analysis shown that DI was a strong independent predictor of appearance of ED, together with PAI-1 and LDL particle size. Conclusions: Both insulin resistance and impairment in insulin secretion response strongly correlate with coronary ED in subjects without diabetes. © 2018 Elsevier B.V.
| EMTREE drug terms: | acetylcholineinsulinlipoproteinplasminogen activator inhibitor 1 |
|---|---|
| EMTREE medical terms: | adultArticleclinical articlecontrolled studycoronary angiographycoronary arterycoronary artery diseasecoronary artery spasmcorrelation analysisdisease associationdisposition indexendothelial dysfunctionfemalegel electrophoresishomeostasis model assessmenthumaninsulin releaseinsulin resistanceintravenous glucose tolerance testlipoprotein blood levelmalemiddle agedparticle sizeprotein blood levelrating scalecoronary blood vesselendothelium cellinsulin resistancemetabolismpathologyphysiology |
| MeSH: | Coronary VesselsEndothelial CellsFemaleHumansInsulin ResistanceMaleMiddle Aged |
acetylcholine, 51-84-3, 60-31-1, 66-23-9; insulin, 9004-10-8; plasminogen activator inhibitor 1, 140208-23-7
This study was supported by the grant number 175097 from Ministry of Sciences Republic of Serbia .
Lalić, K.; Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Dr. Subotića 13, Belgrade, Serbia;
© Copyright 2018 Elsevier B.V., All rights reserved.